• How does niacin influence non-alcoholic fatty liver outcomes?

    A recent study investigated if niacin (vitamin B3) intake can reduce the general and cardiovascular mortality of those affected by NAFLD

  • Hand osteoarthritis: oral therapy or injections?

    Hand osteoarthritis is often stressful for those affected and accompanied functional restrictions. Effective treatment options are essential.

  • A skin patch to monitor health data?

    Researchers developed a wearable patch that can continuously monitor blood glucose, lactates and other vital health indicators for weeks.

  • World's first chikungunya vaccine also authorised in Europe

    This expands the fight against the infection caused by invasive mosquito species, which could rise in Europe as average temperatures rise.

  • GLP-1 RA drugs for T2 diabetes and obesity

    GLP-1 RA drugs promise to revolutionise diabetes and obesity therapy. But further studies are needed on adverse effects and new uses.

  • Overweight and obesity: does semaglutide have a cardioprotective effect?

    The GLP-1 receptor agonist semaglutide improves diabetes cardiovascular outcomes. What about patients who inject it for weight loss?

  • Biliary atresia: is maternal infection a risk factor?

    A case-control study investigated whether a maternal infection during pregnancy can increase the child's risk of developing biliary atresia.

  • Social Media: A gateway to the heart of dermatosis patients?

    Many patients share difficulties and other disease-related information on social media. This data can be useful, according to a recent study.

  • Implications of a pregnancy during a medical specialisation

    A study investigated USA general surgery residents' experiences, highlighting the needs to protect maternal and foetal health, and promote gender equity.

  • Medical Case: What is behind this recurrent "shingles"?

    A patient shows recurring inflammatory pustules in his buttocks. Shingles is diagnosed in the last medical check, but is this diagnosis really correct?

  • HBV vaccination for rheumatism: ideal before biologics treatment

    Researchers investigated the immune response to HBV vaccination in patients with rheumatic diseases treated with biologics. Results are promising.

  • Thinking minds, guilty thoughts, and the guillotine debate

    The guillotine intended to avoid unnecessary agony in an execution. Was death instant though? We check if this question was settled, or not.

  • Interview: The future of gastrointestinal oncology

    This interview after the 'ESMO GI Cancers 2024' congress was an opportunity for in-depth study and discussion of new developments in GI oncology.

  • Treating GI tumours in geriatric patients

    Gastrointestinal tumours occur most frequently in people over 70. But how does the treatment of geriatric patients differ from that of younger patients?

  • Salmonella infection: is tomato juice a treatment option?

    Could bacteria or viruses be rendered harmless by tomatoes or its products? Researchers investigated if tomato substances work against S. typhi.

  • The effect of puberty onset on cardiovascular risk

    Is an earlier onset of puberty and hormone fluctuations associated with an increased cardiometabolic risk in adulthood?

  • Amblyopia in childhood: a risk factor later in life

    The link between childhood amblyopia and later cardiometabolic dysfunction has been known for some time But how high is amblyopia's risk?

  • Could poor air quality in aeroplanes pose health risks?

    The air you breathe in aircrafts is routinely contaminated by small amounts of engine oils and hydraulic fluids. Could these pollutants be harmful?

  • Gynaecological oncology: present and future

    During the ESMO Congress on Gynaecological Cancers, Prof. Scambia analysed developments in the field, and what's next in the coming decade.

  • Colon carcinoma: current biomarker tools and new developments

    Precision medicine is revolutionising treatments for colon cancer and other gastrointestinal malignancies by identifying biomarkers for personalised therapies.

  • 2 |
  • 3 |
  • 4 |
  • 5 |
  • 6 |
  • 7 |
  • 8 |
  • 9 |
  • 10 |
  • 11 |
  • 12 |